ARTICLE | Company News
Management Tracks: Agios’ Biller to retire as CSO; plus Vectura, Molecular Partners, F-star and more
June 11, 2019 11:29 PM UTC
Updated on Oct 29, 2019 at 11:13 PM UTC
Agios Pharmaceuticals Inc. (NASDAQ:AGIO) said CSO Scott Biller will retire at year end. The cellular metabolism company is searching for a successor.
Vectura Group plc (LSE:VEC) said CFO Paul Fry will serve as interim CEO when James Ward-Lilley steps down from the board and as CEO on June 30. The inhaled drug delivery platform company has begun its search for a new CEO...